SCHEDULE 13G//SEC Filing
Lyell Immunopharma, Inc. SCHEDULE 13G
Accession 0001140361-25-042006
CIK 0002095697other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:04 PM ET
Size
6.8 KB
Accession
0001140361-25-042006
Documents
Issuer
Innovative Cellular Therapeutics Holdings Ltd
CIK 0002095697
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0002095697
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:04 PM ET
- Size
- 6.8 KB